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Abstract
Aims: Temperament and impulsivity are powerful predictors of addiction treatment
outcomes. However, a comprehensive assessment of these features has not been
examined in relation to smoking cessation outcomes.
Methods: Naturalistic prospective study. Treatment-seeking smokers (n5140)
were recruited as they engaged in an occupational health clinic providing smoking
cessation treatment between 2009 and 2013. Participants were assessed at
baseline with measures of temperament (Temperament and Character Inventory),
trait impulsivity (Barratt Impulsivity Scale), and cognitive impulsivity (Go/No Go,
Delay Discounting and Iowa Gambling Task). The outcome measure was treatment
status, coded as ‘‘dropout’’ versus ‘‘relapse’’ versus ‘‘abstinence’’ at 3, 6, and 12
months endpoints. Participants were telephonically contacted and reminded of
follow-up face to face assessments at each endpoint. The participants that failed to
answer the phone calls or self-reported discontinuation of treatment and failed to
attend the upcoming follow-up session were coded as dropouts. The participants
that self-reported continuing treatment, and successfully attended the upcoming
follow-up session were coded as either ‘‘relapse’’ or ‘‘abstinence’’, based on the
results of smoking behavior self-reports cross-validated with co-oximetry
hemoglobin levels. Multinomial regression models were conducted to test whether
temperament and impulsivity measures predicted dropout and relapse relative to
abstinence outcomes.
Results: Higher scores on temperament dimensions of novelty seeking and reward
dependence predicted poorer retention across endpoints, whereas only higher
scores on persistence predicted greater relapse. Higher scores on the trait
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dimension of non-planning impulsivity but not performance on cognitive impulsivity
predicted poorer retention. Higher non-planning impulsivity and poorer performance
in the Iowa Gambling Task predicted greater relapse at 3 and 6 months and 6
months respectively.
Conclusion: Temperament measures, and specifically novelty seeking and reward
dependence, predict smoking cessation treatment retention, whereas persistence,
non-planning impulsivity and poor decision-making predict smoking relapse.
Introduction
An outstanding challenge for smoking cessation interventions is the detection of
individual differences associated with poor treatment outcomes, especially in
relation with long-term relapse [1, 2]. Individual differences in temperament and
impulsivity are increasingly recognised as powerful predictors of addiction
treatment outcomes, including smoking cessation outcomes [3]. Temperament
refers to stable dispositions determining motivated behaviour [4]. Cloninger’s
model posits the existence of four major dimensions of temperament: novelty
seeking, harm avoidance, reward dependence and persistence [4]. There is
evidence that novelty seeking and harm avoidance are increased and persistence is
decreased in heavy smokers [5]. However, only novelty seeking has been studied
in relation to smoking cessation outcomes. Specifically, higher levels of novelty
seeking associate with lower abstinence rates at mid-term (2 to 6 months) and
long-term (12 months) follow-ups [6, 7]. This association is at least partly
explained by poorer treatment retention in high novelty seekers [7]. Impulsivity
refers to the tendency to engage in rapid behaviour without adequate forethought
about the potential consequences of this behaviour [8]. Current theories
differentiate between trait and cognitive aspects of impulsive behaviour, with trait
aspects representing personality features leading to impulsive outcomes, and
cognitive aspects representing the moment-to-moment function of the cognitive
processes that regulate impulse control [9, 10]. Trait aspects include motor,
attentional and non-planning impulsivity [11] and cognitive aspects include
response inhibition, delay discounting and reward/punishment-based decision-
making skills [11]. Several studies have shown that separate aspects of trait and
cognitive impulsivity are significantly associated with smoking cessation out-
comes. Specifically, higher levels of trait impulsivity associate with short-term and
mid-term smoking relapse (i.e., 1 week and 3 months respectively) [12, 13].
Further, poorer performance on response inhibition or delay discounting
measures associates with mid-term smoking relapse (3 to 6 months) [13, 14].
However, no studies to date have thoroughly mapped the link between the
multimodal (i.e., trait and cognitive) and multifaceted (i.e., separate dimensions
of trait and cognitive) aspects of impulsivity and smoking cessation outcomes.
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In addition, the broader literature on the link between individual differences
and addiction treatment outcomes has provided growing insights about the
association between temperament, impulsivity and treatment outcomes, which
have not yet been examined in smoking cessation studies. Firstly, there is evidence
to suggest that the link between specific aspects of temperament and impulsivity
and addiction treatment outcomes differ as a function of the type of outcomes
(i.e., retention versus relapse) and the timing of endpoints. For example, in opiate
using populations higher levels of novelty seeking are associated with better
treatment commitment during the first weeks of combined pharmacological and
behavioural interventions, but lower treatment retention by 3-month follow-up
[15]. It is plausible to think that other temperament dimensions (i.e., persistence)
may contribute to explain why novelty seekers disengage from addiction
treatment outcomes in the long-term [16]. Further, in stimulant using
populations, higher levels of impulsivity are associated with better retention in
combined pharmacological and contingency management interventions [17], but
lower abstinence rates during and following interventions [18]. Both findings are
relevant for smoking treatment, since combined pharmacological and behavioural
interventions for smoking are typically associated with good short-term retention
rates yet high levels of long-term relapse [1]. Furthermore, in multimodal
assessments of cognitive impulsivity the dimension of decision-making seems to
be a significantly stronger predictor of alcohol and opiates relapse relative to other
impulsivity indices [19, 20]. This association is particularly robust in outpatient
settings [21] and seems to generalise to long-term outcomes [22]. These findings
are as well relevant for smoking cessation treatment, since interventions of choice
are outpatient-based, and mainly plagued by long-term relapse [1, 2]. Therefore,
temperament and impulsivity are linked to smoking cessation outcomes, but there
is no comprehensive mapping of which dimensions of these features are relevant
(versus irrelevant) to predict different outcomes (retention and relapse) at
different time points (short-term versus mid-term versus long-term endpoints).
Moreover, trait and cognitive measures of impulsivity are often poorly correlated,
and there is growing interest in understanding their relative contribution to
outcomes in multiple regression approaches [23]. In this study, we conducted
multiple measures of temperament and impulsivity at the onset of smoking
cessation treatment including pharmacological and behavioural components, and
utilised these measures to predict retention and relapse at 3, 6 and 12 months
endpoints.
Temperament and impulsivity are theoretically different constructs, with the
former emphasising motivational tendencies and the latter emphasising the degree
of control over these motivational tendencies [24]. Moreover, both constructs
may have different implications for addiction treatment since temperament is
more stable across time [25] whereas impulsivity -even trait impulsivity- is
amenable to addiction interventions [26]. Therefore, we conducted separate
prediction models for temperament measures (novelty seeking, harm avoidance,
reward dependence and persistence) and trait and cognitive impulsivity measures
(motor, attention and non-planning, traits and cognitive, delay discounting and
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decision-making skills). In agreement with existing studies, we hypothesised that
higher novelty seeking and persistence would be associated with greater short-
term and long-term retention and relapse respectively and that poor performance
on the cognitive impulsivity component of decision-making would be associated
both with greater short-term and long-term relapse.
Methods
Design
We conducted a naturalistic prospective study during the course of a smoking
cessation treatment intervention. We utilised baseline psychometric assessments
to predict treatment status at three endpoints: 3 months after treatment
commencement; 6 months after treatment commencement; and 12 months after
treatment commencement. Treatment-seeking smokers were recruited as they
engaged in an occupational health service that provides smoking cessation
treatment including pharmacological and behavioural components between
September 2009 and September 2013. The treatment consisted on three
consecutive phases: (1) psychoeducation and counselling to reduce smoking; (2)
prescription of the drug varenicline, in alignment with the Food and Drug
Administration’s guidelines [27, 28] and (3) training of relapse prevention
strategies. The participants’ compliance with treatment was clinically monitored
through 3 follow-up face to face sessions conducted at 3, 6 and 12 months after
treatment commencement. The researchers telephonically contacted the partici-
pants before each of these follow-up sessions in order to enquire about their
current treatment status: had they discontinued treatment (dropout), had they
relapsed but intended to continue treatment (relapse), or were they abstinent and
intended to continue treatment (abstinence). The treatment program permitted
that participants originally classified as dropouts resumed treatment at a later
stage (i.e., they re-entered phase (3), and clinicians focused on reconsolidating
relapse prevention strategies). We adapted the research design to the treatment
program, and therefore participants classified as dropouts at the 3-month
endpoint could be re-classified as relapse or abstinence at the 6 or 12 months
endpoints. Therefore, the three endpoints are discrete-time events.
Participants
One hundred and forty smokers were recruited across 3 years. The demographic
and smoking behaviour characteristics of the sample are displayed in Table 1.
Participants were eligible if they were current smokers, aged above 18 years old,
and were employed by the service provider (Universidad de Granada). The
exclusion criteria were as follows: history of major mental disorders (i.e., major
depression, psychosis) or current psychotropic medication for psychiatric
symptoms, concurrent dependence on other substances (cocaine, heroin, alcohol,
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etc.), and current use of prescription medications that are incompatible with the
pharmacological treatment used in the therapy.
Setting
The Occupational Health Prevention Service of the Universidad de Granada
(Spain). The service includes a smoking clinic, managed by two physicians and
one psychologist, which provides specialised treatment for smoking cessation
including pharmacological (i.e., varenicline) and behavioral change (counsellin-
g+relapse prevention) components.
Procedures
The study was approved by the Human Ethics Committee of the Universidad de
Granada. All clients commencing treatment at the Occupational Medicine
Prevention Service (n5164) were invited to participate in a prospective study
assessing personality and cognition in relation to smoking behaviour during the
first contact with the clinic. The clients that provided informed consent by signed
and met inclusion and exclusion criteria were scheduled for a baseline assessment
before treatment onset. Subsequent telephone contact points were scheduled at 3,
6, and 12 months after this baseline assessment, before each of the treatment’s
follow-up sessions. Participants were telephonically contacted by an independent
assessor (blind to study purpose and methods) at each endpoint (3, 6 and 12
months) in order to monitor their compliance with the treatment and their
willingness to participate in the follow-up face to face assessments. The
Table 1. Baseline demographic and smoking characteristics of the participants.
Variables Scores
Age (mean and SD) 47.36 (8.19)
Gender (N)





Administrative and Service Personnel 113
Academics/Researchers 27
Years of smoking addiction (mean and SD) 28.49 (10.09)
Number of daily cigarettes (mean and SD) 19.85 (9.17)
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participants that failed to answer the phone calls or self-reported discontinuation
of treatment and failed to attend the upcoming follow-up session were coded as
dropouts. The participants that self-reported continuing treatment, and success-
fully attended the upcoming follow-up session were coded as either ‘‘relapse’’ or
‘‘abstinence’’, based on the results of smoking behavior self-reports cross-
validated with co-oximetry hemoglobin levels. This definition of outcomes
(dropout versus relapse versus abstinence) has been deemed optimal for research
designs embedded in smoking cessation treatment programs [29, 30]. Outcome
data (dropout versus relapse versus abstinence) was obtained for 140 participants
at 3-months, 123 participants at 6 months, and 112 participants at 12 months.
The primary outcome variable (i.e., the classification of participants as dropout or
relapse or abstinence) was assessed and coded independently at each of the
endpoints.
Measures
Semi-structured interview for smokers [31]
This survey provides information about socio-demographic data, family history,
smoking duration, brand of cigarettes, and level of dependence.
Fargerström Test for Nicotine Dependence [32]
This test is composed of 6 items with two or four response alternatives. Its
factorial structure is consistent [33] and there is a Spanish version of the test [34].
Temperament and Character Inventory Revised (TCI-R) [4]
This self-report questionnaire consists of 240 items which participants have to rate
in a 5-point Likert scale. The items are grouped in four main temperament
dimensions (Novelty Seeking, Harm Avoidance, Reward Dependence, and
Persistence) and three character dimensions (Self-directedness, Cooperativeness,
and Self-transcendence).
Barratt Impulsiveness Scale (BIS-11) [11]
This self-report scale consists of 30 items reflecting a collection of typical
impulsivity manifestations. Participants have to rate to what extent these
manifestations apply to them in terms of frequency: never or rarely, occasionally,
often, and always or almost always (scoring from 0 to 4). The main dependent
variable was the total impulsivity score, and three subscale scores: cognitive,
motor, and non-planning impulsiveness.
Go/No Go [35]
The task consisted of 60 trials. In the first 30 trials (pre-switch), participants were
asked to press a key as quickly as they could whenever the go stimulus (a letter)
was presented, and to withhold the response when the no-go stimulus (a different
letter) was presented. In the second 30 trials of the task (post-switch), participants
were asked to respond to the previously no-go stimulus and not to respond to the
previously go stimulus. The proportion of go vs. no-go trials on both phases (pre-
Temperament Impulsivity Smoking Cessation Outcomes
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and post-switch) was 7/3. The inter-stimulus interval (ISI) was set at 100 ms, and
each stimulus was presented during 1000 ms. Auditory feedback (one of two
distinctive sounds) was provided after each response to indicate whether that
response had been right or wrong. Responses were coded as hits (responding in
presence the go trial), false alarms (responding in presence of the no-go trial),
misses (not responding in presence of the go trial), and correct rejections (not
responding in presence of the no-go trial). The main dependent variable from this
test was the false alarm rate, computed as the ratio between the number of false
alarms and the total number of no-go trials (#false alarms+#correct rejections).
Delay-discounting questionnaire (DDT) [36]
This is a monetary-choice questionnaire asking for individual preferences between
smaller, immediate rewards and larger, delayed rewards varying on their value and
time to be delivered. The questionnaire is composed of a fixed set of 27 choices;
the amounts of money and delays used in all 27 trials are reported in [36]. We
calculated the area under the curve (AUC) [37] as the main dependent variable
from this measure. The AUC was calculated for the range of reward magnitudes
included in the questionnaire (small –Euro 25 to 35; medium –Euro 50 to 60; and
large –Euro 75 to 85), according to the formula (x22x1) [(y12y2)/2], where x1
and x2 are successive delays, and y 1 and y 2 are the subjective values associated
with these delays.
Iowa Gambling Task, original version [38]
This is a computer task measuring reward/punishment based decision-making. It
involves four decks of cards (A, B, C and D). Each time a participant selects a card,
a specified amount of play money is awarded. However, interspersed among these
rewards, there are probabilistic punishments (monetary losses). Two of the decks
of cards (A and B) produce high immediate gains; however, in the long run, they
will take more money than they give, and are thus considered disadvantageous.
The other two decks (C and D) are considered advantageous, as they result in
small, immediate gains, but will yield more money than they take in the long run.
The performance measure was the net score calculated by subtracting the number
of disadvantageous choices (decks A and B) from the number of advantageous
choices (decks C and D).
Main outcome measure
Treatment compliance, defined as ‘‘treatment dropout’’ (i.e., non-response to the
phone call or negative response to the query of whether they continue in
treatment and non-attendance to the follow-up session) versus ‘‘smoking
abstinence’’ versus ‘‘smoking relapse’’, as measured by cross-validated self-reports
of the last 3 months and co-oximetry hemoglobin levels sensitive to the last
24 hours. A positive self-report of smoking in the last 3 months and/or a CO level
superior to 10 ppm was utilised to define relapse versus abstinence.
Temperament Impulsivity Smoking Cessation Outcomes
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Statistical analyses
We performed two series of multinomial regression analyses including two sets of
predictors: (1) temperament scores (TCI’s scores on dimensions of novelty
seeking, harm avoidance, reward dependence and persistence), and (2)
impulsivity scores from trait measures (BIS motor, cognitive and non-planning
impulsivity) and cognitive tests (Go/No Go false alarms, Delay Discounting area
under the curve and Iowa Gambling Task net scores). The dependent variable was
the type of outcome, representing whether participants had (1) dropped out from
treatment (Treatment Dropout), (2) relapsed during treatment (Relapse), or (3)
maintained abstinence during treatment (Abstinence). This outcome measure was
coded at each of the follow-up time points: 3 months, 6 months, and 12 months.
In all the regression models, we set ‘‘maintained abstinence during treatment’’
(Abstinence) as the reference category, such that models tested which variables
were significantly associated with Treatment Dropout or Relapse, relative to
Abstinence. Multinomial regression analyses are the best-suited approach for the
study design as they model the impact of several predictors on outcomes of
multiple categories [39]. In addition, we conducted sensitivity analyses utilising
bivariate logistic regression models separate for dropouts versus completers, and
for abstinence versus relapse.
Results
Number of cases that drop-out, relapse or maintain abstinence at
each of the follow-up time points
At the 3-month follow-up (n5140), 32 participants had dropped out from
treatment, 27 participants had relapsed during treatment, and 81 participants had
maintained abstinence during treatment. At the 6-month follow-up (n5123), 30
participants had dropped out from treatment, 37 participants had relapsed during
treatment, and 56 participants had maintained abstinence during treatment. At
the 12-month follow-up (n5112), 28 participants had dropped out from
treatment, 40 participants had relapsed during treatment, and 44 participants had
maintained abstinence during treatment. Participants classified in each of these
categories (dropout versus relapse versus abstinence) at each of the three follow-
ups did not significantly differ in demographic or baseline smoking behaviour
characteristics (see Table 2).
Multinomial regression models of temperament measures
predicting follow-up outcome (Drop-out and Relapse vs.
Abstinence)
For the 3-month follow-up outcome, the model including TCI scores showed
satisfactory fit, x2525.15, d.f.58, p,0.01, explaining 19% of variance, Nagelkerke
pseudo-R250.19. Inspection of parameter estimates showed that the dimension of
novelty seeking, Wald statistic59.40, p50.002, and the dimension of reward
Temperament Impulsivity Smoking Cessation Outcomes
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Table 2. Baseline demographic and variables related to cigarette smoking of the participants classified in each of these categories (dropout versus relapse
versus abstinence).
Variables DROPOUT RELAPSE ABSTINENT F/x2 p
3-month follow-up
Age (mean and SD) 47.53 (8.56) 47.74 (8.48) 47.17 (8.05) .056 .945
Gender (N)
Male (Female) 11 (21) 11 (16) 33 (48) 2 .811
Education (N)
Primary/Secondary 18 16 42 .512 .774
Tertiary/Ph.D. 14 11 39
Career (N) 1.071 .585
Administrative and Service Personnel 27 20 66
Academics/Researchers 5 7 15
Years of smoking addiction (mean and SD) 29.94 (10.65) 29.44 (10.21) 27.60 (9.86) .759 .470
Number of cigarettes per day (mean and SD) 22.00 (10.43) 20.85 (8.09) 18.67 (8.89) 1.735 .180
Fagerström scores (mean and SD) 4.75 (2.31) 4.63 (2.39) 4.62 (2.32) .038 .962
Cigarettes Brand (N)
Blonde 28 23 69 .657 .957
Black Tobacco 2 3 7
Rolling 2 1 5
6-month follow-up
Age (mean and SD) 47.13 (8.62) 47.43 (9.68) 47.04 (6.91) .026 .974
Gender (N)
Male (Female) 11 (19) 15 (22) 25 (31) .531 .767
Education (N) .412 .814
Primary/Secondary 16 21 28
Tertiary/Ph.D. 14 16 28
Career (N) .328 .849
Administrative and Service Personnel 25 29 44
Academics/Researchers 5 8 12
Years of smoking addiction (mean and SD) 29.87(10.98) 28.35 (11.75) 27.50(8.81) .516 .598
Number of cigarettes per day (mean and SD) 21.83(10.47) 19.78 (7.90) 18.55 (8.74) 1.312 .273
Fagerström scores (mean and SD) 4.80 (2.37) 4.68 (2.16) 4.38 (2.30) .398 .672
Cigarettes Brand (N)
Blonde 26 32 47 1.828 .767
Black Tobacco 2 4 4
Rolling 2 1 5
12-month follow-up
Age of the respondents (mean and SD) 46.62 (8.84) 48.55 (8.44) 45.77 (7.44) 1.224 .298
Gender (N) .674 .714
Male (Female) 10 (18) 17 (23) 20 (24)
Education (N) 1.826 .401
Primary/Secondary 15 23 19
Tertiary/Ph.D. 13 17 25
Career (N) 1.749 .417
Administrative and Service Personnel 24 29 35
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dependence, Wald statistic55.28, p50.02, were significantly and directly
associated with Treatment Dropout. None of the temperament dimensions were
significantly associated with relapse at 3 months.
For the 6-month follow-up outcome, the model including TCI scores showed
satisfactory fit, x2531.79, d.f.58, p,0.001, explaining 26% of variance, Nagelkerke
pseudo-R250.26. Inspection of parameter estimates showed that the dimensions of
novelty seeking, Wald statistic58.75, p50.003, reward dependence, Wald
statistic53.93, p50.047, and persistence, Wald statistic56.45, p50.01, were
significantly and directly associated with Treatment Dropout. Moreover, the
dimension of persistence was also significantly associated with Relapse at 6
months, Wald statistic55.90, p50.02.
For the 12-month follow-up outcome, the model including TCI scores showed
satisfactory fit, x2524.55, d.f.58, p,0.01, explaining 22% of variance, Nagelkerke
pseudo-R250.22. Inspection of parameter estimates showed that the dimensions of
novelty seeking, Wald statistic56.67, p50.01, and reward dependence, Wald
statistic53.83, p50.05, were significantly and directly associated with Treatment
Dropout. None of the temperament dimensions were significantly associated with
Relapse at 12 months (see Table 3).
Multinomial regression models of impulsive measures predicting
follow-up outcome (Drop-out and Relapse vs. Abstinence)
For the 3-month follow-up outcome, the model including trait and cognitive
impulsivity scores showed satisfactory fit, x2560.31, d.f.512, p,0.001, explaining
41% of variance, Nagelkerke pseudo-R250.41. Inspection of parameter estimates
showed that the BIS dimension of non-planning impulsivity was significantly and
positively associated with both Treatment Dropout, Wald statistic56.02, p50.01,
and Relapse, Wald statistic55.34, p50.02.
For the 6-month follow-up outcome, the model including trait and cognitive
impulsivity scores showed satisfactory fit, x2564.39, d.f.512, p,0.001, explaining
46% of variance, Nagelkerke pseudo-R250.46. Inspection of parameter estimates
showed that the BIS dimension of non-planning impulsivity was significantly and
positively associated with Treatment Dropout, Wald statistic54.69, p50.03.
Table 2. Cont.
Variables DROPOUT RELAPSE ABSTINENT F/x2 p
Academics/Researchers 4 11 9
Years of smoking addiction (mean and SD) 29.39 (11.22 29.50 (10.62) 26.41 (9.50)) 1.158 .318
Number of cigarettes per day (mean and SD) 21.61 (10.73) 19.98 (7.82) 19.16 (9.10) .620 .540
Fagerström scores (mean and SD) 4.57 (2.27) 4.75 (2.30) 4.48 (2.26) .153 .858
Cigarettes Brand (N)
Blonde 24 35 37 6.092 .192
Black Tobacco 2 5 2
Rolling 2 0 5
doi:10.1371/journal.pone.0112440.t002
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Moreover, both non-planning impulsivity, Wald statistic54.69, p50.03, and Iowa
Gambling Task performance, Wald statistic54.19, p50.04, were significantly and
positively associated with Relapse.
For the 12-month follow-up outcome, the model including trait and cognitive
impulsivity scores showed satisfactory fit, x2551.5, d.f.512, p,0.001, explaining
42% of variance, Nagelkerke pseudo-R250.42. Inspection of parameter estimates
showed that the BIS dimension of attentional impulsivity was significantly and
positively associated with Treatment Dropout, Wald statistic54.21, p50.04. None
of the predictors were significantly associated with Relapse (see Table 4).
Sensitivity analyses
Bivariate logistic regression models separate for dropouts versus completers and
relapse versus abstinence yielded very similar results to the main multinomial
regression approach (see the Tables displaying the results of these analyses in File
S1). In regards to temperament, higher novelty seeking and higher reward
dependence predicted greater dropout across endpoints, and only higher
persistence predicted greater relapse versus abstinence. In regards to impulsivity,
higher BIS non-planning impulsivity and lower Iowa Gambling Task performance
predicted greater relapse across 3 and 6 months and at 6 months respectively.
Discussion
We demonstrate that temperament and impulsivity are significant predictors of
smoking treatment outcomes. Higher scores on temperament measures of novelty
Table 3. Multinomial regression models testing the association between TCI temperament dimensions and smoking cessation treatment dropout and
relapse at the 3-month, 6-month and 12-month endpoints.
Temperament
Predictors Three months Six months Twelve months






































































Temperament Impulsivity Smoking Cessation Outcomes
PLOS ONE | DOI:10.1371/journal.pone.0112440 December 4, 2014 11 / 18
seeking and reward dependence and on the impulsive trait of non-planning
impulsivity were significantly associated with treatment dropout. In addition,
higher scores on the temperament measure of persistence and on the impulsive
trait of non-planning impulsivity, and poorer decision-making performance in
the Iowa Gambling Task uniquely predicted objectively indexed smoking relapse.
Sensitivity analyses further showed that higher novelty seeking and higher reward
dependence are consistently associated with dropout. Moreover, higher
persistence and non-planning impulsivity and poorer decision-making perfor-
mance are consistently associated with relapse during later stages of treatment.
These results indicate that baseline temperament and impulsivity measures are
useful to prospectively predict smoking treatment outcomes, such that they can be
utilised to identify clients at higher risk of poor outcomes, to match clients’
profiles with adequate treatment options, or to design specific interventions for
at-risk participants.
Our first finding refers to the association between novelty seeking, reward
dependence and trait impulsivity with treatment drop-out. The link between
novelty seeking and dropout is in fitting with previous evidence demonstrating
that high sensation seeking is associated with poorer treatment response to
smoking cessation motivational interventions [40]. This finding is also
reminiscent of the broader substance use treatment literature, whereby several
studies have shown that alcohol and substance using clients scoring higher on
novelty seeking are more susceptible to dropout as soon as the novelty of
treatment fades out [7, 15]. We also showed, for first time, that the temperament
dimension of reward dependence is linked to smoking treatment dropout.
Table 4. Multinomial regression models testing the association between trait and cognitive impulsivity and smoking cessation treatment dropout and relapse
at the 3-month, 6-month and 12-month endpoints.
Impulsivity
Predictors Three months Six months Twelve months























































































*p,0.05. DDT, Delay Discounting Task; GNG, Go No-Go Task; IGT, Iowa Gambling Task.
doi:10.1371/journal.pone.0112440.t004
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Interestingly, reward dependence was the only temperament measure correlated
with steeper discounting of delayed reward, which has been linked to smoking
treatment outcomes in previous studies [13, 41] and which showed a sizeable
(although non-significant) contribution to dropout in this sample. Moreover, we
showed that non-planning and attentional dimensions of impulsivity are linked to
higher treatment dropout. This finding was expected, considering that the
beneficial outcomes of smoking interventions are not immediate [42] such that
adequate focus on long-term goals is required to continue with treatment. Our
results regarding prediction of dropout suggest different routes for improving
engagement in smoking cessation. Since temperament is regarded as a stable
disposition [25], temperament-based treatment matching could be utilised to
allocate clients to tailored treatment options. For example, novelty seekers are
likely to stick to programs with varied stimulation and challenges. Similarly,
reward dependent clients could get unique benefit from contingency management
interventions [43]. Although non-planning impulsivity is also regarded as a trait,
novel evidence has revealed that trait dispositions are malleable to self-regulation
interventions [44].
Our second finding refers to the association between persistence, non-planning
impulsivity and decision-making with smoking relapse. Persistence was originally
defined as perseverance despite frustration [4] which might be viewed as an
advantageous disposition for smoking cessation, and specifically for early stages of
treatment. However, high persistence scores are associated with resistance to
extinction of previously rewarded behaviours [45]. Therefore, highly persistent
clients are purportedly more prone to perseverate on stimulus-bound instru-
mental behaviours, and therefore more vulnerable to relapse in the long-term.
Non-planning impulsivity refers to lack of forethought about the long-term
outcomes of acts and decisions [11]. Previous studies had shown that overall trait
impulsivity levels are associated with smoking relapse following treatment [13, 46]
but this is the first study to show that this particular dimension is significantly
associated with relapse. Moreover, disadvantageous (reward-driven, risk-insensi-
tive) decision-making in the Iowa Gambling Task was also significantly predictive
of smoking relapse, in agreement with findings from animal studies [47] and
human studies predicting relapse in other substance using populations [19, 20].
Interestingly, the three significant predictors of smoking relapse (persistence, non-
planning impulsivity and decision-making) share an overlapping neural substrate
in the medial orbitofrontal cortex [48–51]. This region is specialised in integrating
emotional states with stimulus-outcome representations, and is therefore critical
to estimate the risk and to anticipate the consequences of our decisions.
Therefore, our results suggest that tailored interventions directed to target these
mechanisms, such as self-regulation training or episodic future thinking [52, 53],
could be effective to improve treatment outcomes in smoking cessation.
This study shows that novelty seeking, reward dependence and non-planning
impulsivity are significant predictors of smoking treatment dropout, whereas
persistence, non-planning impulsivity and decision-making are significant
predictors of smoking relapse. Harm avoidance and motor impulsivity do not
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significantly predict poor smoking treatment outcomes, and delay discounting
showed only a trend in predicting retention. The strength of prediction effects is
higher for impulsivity than for temperament measures. Since impulsivity is as well
more malleable than temperamental dispositions, our findings suggest that
tailored interventions aimed to enhance impulse control and to direct motivation
towards long-term goals may increase efficacy of smoking treatment programs.
The main strengths of this study include the relatively large sample size, the
multidimensional assessment of trait and cognitive domains, and the objective
measurement of relapse. Our results should be as well understood in the context
of relevant limitations. First, the study design was naturalistically embedded in the
context of a health promotion intervention (i.e., individuals who dropped-out at
an earlier stage could re-engage at a later stage). Therefore, the different endpoints
cannot be interpreted from a longitudinal perspective, but as discrete time-points.
Future studies are warranted to examine whether the observed associations stand
in a purely longitudinal design using survival analyses approaches. Further,
treatment participants were all employees of the same institution, the University
of Granada, and there may be a concern that the sample is not representative of
clinical populations. However, since smoking is a broad community-spread
problem, and participants belonged to different strata of the University make-up
(academics, professionals, and administrative staff), the sample is sufficiently
diverse to be representative of the general population. Another potential
limitation is the exclusion of participants with Axis I disorders, which probably
precludes inclusion of individuals in the upper extreme of the constructs
examined (e.g., novelty seeking, impulsivity). However, this only means that the
sample is more representative of smoking cessation outcomes in the community
versus specific clinical settings. Moreover, even though abstinence was cross-
validated with self-report and haemoglobin levels, both assessment methods are
subjected to biases, such as reliability of retrospective reports (self-report) and
time-limited scope (co-oximetry haemoglobin levels). Multiple tests may raise
concerns about Type I error, but results were highly consistent with hypotheses,
and the main findings were supported by the sensitivity analyses. Special caution
must be taken with unpredicted results, such as the association between
attentional impulsivity and long-term relapse. Collectively, our findings
demonstrate that temperament is essential for prediction of smoking treatment
retention, and that both temperament and impulsivity dimensions associated with
long-term based decision-making (persistence, non-planning impulsivity, cogni-
tive-affective decision making) are important for prediction of smoking relapse.
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35. Verdejo-Garcı́a AJ, Perales JC, Pérez-Garcı́a M (2007) Cognitive impulsivity in cocaine and heroin
polysubstance abusers. Addict Behav 32(5):950–66. Available: http://www.sciencedirect.com/science/
article/pii/S0306460306002164. Accessed 2005 May 30.
36. Kirby KN, Petry NM, Bickel WK (1999) Heroin addicts have higher discount rates for delayed rewards
than non-drug-using controls. J Exp Psychol Gen 128(1):78–87. doi:10.1037/0096-3445.128.1.78
37. Myerson J, Green L, Warusawitharana M (2001) Area under the curve as a measure of discounting.
J Exp Anal Behav 76(2):235–43. doi: 10.1901/jeab.2001.76-235.
38. Bechara A, Damasio H, Damasio AR (2000) Emotion, decision making and the orbitofrontal cortex.
Cereb Cortex 10(3):295–307. Available: http://cercor.oxfordjournals.org/content/10/3/295.long.
Accessed 2005 May 30.
39. Agresti A (2002) Categorical Data Analysis. Second Edition. Gainesville, Florida: Wiley-Interscience.
40. Helstrom A, Hutchison K, Bryan A (2007) Motivational enhancement therapy for high-risk adolescent
smokers. Addict Behav 32(10):2404–10. Available: http://www.sciencedirect.com/science/article/pii/
S0306460307000743. Accessed 2005 May 30.
41. Mueller ET, Landes RD, Kowal BP, Yi R, Stitzer ML, et al. (2009) Delay of smoking gratification as a
laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of
executive function. Behav Pharmacol 20(5–6):461–73. doi: 10.1097/FBP.0b013e3283305ec7.
42. Ashare RL, Tang KZ, Mesaros AC, Blair IA, Leone F, et al. (2012) Effects of 21 days of varenicline
versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
J Psychopharmacol 26(10):1383–90. doi: 10.1177/0269881112449397.
43. Washio Y, Higgins ST, Heil SH, McKerchar TL, Badger GJ, et al. (2011) Delay discounting is
associated with treatment response among cocaine-dependent outpatients. Exp Clin Psychopharmacol
19(3):243–8. doi:10.1037/a0023617.
44. Delgado-Rico E, Rı́o-Valle JS, Albein-Urios N, Caracuel A, González-Jiménez E, et al. (2012)
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